Xing-dong Cai

Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model

Joseph Mugaanyi, L. Dai, Mingjun Dong, 2022, Scientific Reports.

MMP1 is a Promiseful Prognostic Biomarker and Correlating with Immune Infiltrates in Hepatocellular Carcinoma

Haihong Shi, Tongyue Zhang, Lei Dai, 2021 .

A Comprehensive Pan-Cancer Analysis of the Tumorigenic Effect of Leucine-Zipper-Like Transcription Regulator (LZTR1) in Human Cancer

Yingcong Chen, Xing-dong Cai, Xinyu Ying, 2022, Oxidative medicine and cellular longevity.

Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma

Joseph Mugaanyi, L. Dai, Caide Lu, 2022, Scientific Reports.

A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas

Tongyue Zhang, Joseph Mugaanyi, L. Dai, 2022, PloS one.

[A novel mutation of the SLC34A2 gene in a Chinese pedigree with pulmonary alveolar microlithiasis].

Cheng-ping Hu, Hua-ping Nie, Xing-dong Cai, 2009, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics

Ge Liu, D. He, Ying-Gui Yang, 2021, Translational cancer research.

Constructing a molecular subtype model of colon cancer using machine learning

Xing-dong Cai, Jiazi Yu, Shugeng Wu, 2022, Frontiers in Pharmacology.

Therapeutic effectiveness and safety of sintilimab-dominated triple therapy in unresectable hepatocellular carcinoma

Joseph Mugaanyi, L. Dai, Caide Lu, 2021, Scientific Reports.